Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multi-platform proteomic analysis of Alzheimer’s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome
Eric B. Dammer, Lingyan Ping, Duc M. Duong, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 105

Showing 1-25 of 105 citing articles:

Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease
Erik C. B. Johnson, Shijia Bian, Rafi U. Haque, et al.
Nature Medicine (2023) Vol. 29, Iss. 8, pp. 1979-1988
Open Access | Times Cited: 93
Cerebrospinal fluid proteomics in patients with Alzheimer’s disease reveals five molecular subtypes with distinct genetic risk profiles
Betty M. Tijms, Eleonora M. Vromen, Olav Mjaavatten, et al.
Nature Aging (2024) Vol. 4, Iss. 1, pp. 33-47
Open Access | Times Cited: 81
Proteomic analysis of Alzheimer’s disease cerebrospinal fluid reveals alterations associated with APOE ε4 and atomoxetine treatment
Eric B. Dammer, Anantharaman Shantaraman, Lingyan Ping, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 753
Open Access | Times Cited: 16
Proteomics of brain, CSF, and plasma identifies molecular signatures for distinguishing sporadic and genetic Alzheimer’s disease
Yun Ju Sung, Chengran Yang, Joanne Norton, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 703
Open Access | Times Cited: 40
Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer’s disease
Erica Modeste, Lingyan Ping, Caroline M. Watson, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 38
Quantitative Mass Spectrometry Analysis of Cerebrospinal Fluid Protein Biomarkers in Alzheimer’s Disease
Caroline M. Watson, Eric B. Dammer, Lingyan Ping, et al.
Scientific Data (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 33
CSF proteomics in autosomal dominant Alzheimer’s disease highlights parallels with sporadic disease
Emma L. van der Ende, Sjors G. J. G. In ‘t Veld, Iris Hanskamp, et al.
Brain (2023) Vol. 146, Iss. 11, pp. 4495-4507
Open Access | Times Cited: 30
Batch correction and harmonization of –Omics datasets with a tunable median polish of ratio
Eric B. Dammer, Nicholas T. Seyfried, Erik C. B. Johnson
Frontiers in Systems Biology (2023) Vol. 3
Open Access | Times Cited: 28
Multiplex cerebrospinal fluid proteomics identifies biomarkers for diagnosis and prediction of Alzheimer’s disease
Yu Guo, Shi-Dong Chen, Jia You, et al.
Nature Human Behaviour (2024) Vol. 8, Iss. 10, pp. 2047-2066
Closed Access | Times Cited: 13
Proteomic changes in the human cerebrovasculature in Alzheimer's disease and related tauopathies linked to peripheral biomarkers in plasma and cerebrospinal fluid
Aleksandra Wojtas, Eric B. Dammer, Qi Guo, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 6, pp. 4043-4065
Open Access | Times Cited: 12
Integrative proteomics identifies a conserved Aβ amyloid responsome, novel plaque proteins, and pathology modifiers in Alzheimer’s disease
Yona Levites, Eric B. Dammer, Yong Ran, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 8, pp. 101669-101669
Open Access | Times Cited: 11
Reactive astrocytes secrete the chaperone HSPB1 to mediate neuroprotection
Fangjia Yang, Paula Beltran-Lobo, Katherine Sung, et al.
Science Advances (2024) Vol. 10, Iss. 12
Open Access | Times Cited: 10
Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease
Elisabet A. Frick, Valur Emilsson, Þórarinn Jónmundsson, et al.
Nature Aging (2024) Vol. 4, Iss. 10, pp. 1446-1464
Open Access | Times Cited: 9
Plasma protein-based organ-specific aging and mortality models unveil diseases as accelerated aging of organismal systems
Ludger J.E. Goeminne, Anastasiya V. Vladimirova, Alec Eames, et al.
Cell Metabolism (2024)
Closed Access | Times Cited: 9
Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer’s disease
Daniel Western, Jigyasha Timsina, Lihua Wang, et al.
Nature Genetics (2024) Vol. 56, Iss. 12, pp. 2672-2684
Open Access | Times Cited: 9
Longitudinal plasma proteomics reveals biomarkers of alveolar-capillary barrier disruption in critically ill COVID-19 patients
Erik Duijvelaar, Jack Gisby, James E. Peters, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Proteostasis disruption and senescence in Alzheimer’s disease pathways to neurodegeneration
Riya Thapa, Asif Ahmad Bhat, Moyad Shahwan, et al.
Brain Research (2024) Vol. 1845, pp. 149202-149202
Closed Access | Times Cited: 8
CSF proteomics identifies early changes in autosomal dominant Alzheimer’s disease
Yuanyuan Shen, Jigyasha Timsina, Gyujin Heo, et al.
Cell (2024) Vol. 187, Iss. 22, pp. 6309-6326.e15
Open Access | Times Cited: 8
Proteomic Insight Into Alzheimer's Disease Pathogenesis Pathways
Taekyung Ryu, Kyungdo Kim, Nicholas Asiimwe, et al.
PROTEOMICS (2025)
Open Access | Times Cited: 1
Glymphatic system clearance and Alzheimer’s disease risk: a CSF proteome-wide study
Natàlia Cullell, Giovanni Caruana, Andrea Elias-Mas, et al.
Alzheimer s Research & Therapy (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Plasma Proteomic Kinetics in Response to Acute Exercise
Michael Mi, Jacob L. Barber, Prashant Rao, et al.
Molecular & Cellular Proteomics (2023) Vol. 22, Iss. 8, pp. 100601-100601
Open Access | Times Cited: 22
Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative Dementias
Charlotte E. Teunissen, Leighann Kimble, Sherif Bayoumy, et al.
Molecular & Cellular Proteomics (2023) Vol. 22, Iss. 10, pp. 100629-100629
Open Access | Times Cited: 22
Identification of disulfidptosis-related genes and subgroups in Alzheimer’s disease
Shijia Ma, Dan Wang, Daojun Xie
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 21
Plasma proteomics of SARS-CoV-2 infection and severity reveals impact on Alzheimer’s and coronary disease pathways
Lihua Wang, Daniel Western, Jigyasha Timsina, et al.
iScience (2023) Vol. 26, Iss. 4, pp. 106408-106408
Open Access | Times Cited: 17
Methods and clinical biomarker discovery for targeted proteomics using Olink technology
Han Wang, Tian Zhao, Jingjing Zeng, et al.
PROTEOMICS - CLINICAL APPLICATIONS (2024) Vol. 18, Iss. 5
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top